相关实验视频

Updated: Jan 7, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

全蛋白质组协会研究确定了与阿尔茨海默病相关的新型蛋白质

Lingyun Sun¹, Guikang Wei¹, Feiyang Ji^2,3

¹The Second Affiliated Hospital, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.

Journal of Alzheimer's disease : JAD

|December 29, 2025

概括

这项研究确定了13种与阿尔茨海默病 (AD) 风险和大脑变化相关的新型血蛋白. 这些发现为AD机制和潜在的治疗点提供了新的见解.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
生物化学生物化学

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,治疗干预有限.
确定影响AD风险和进展的因素对于制定有效策略至关重要.

研究的目的:

识别与阿尔茨海默病 (AD) 和相关的认知表型相关的具有基因调节水平的血蛋白.
探索这些蛋白质,AD风险和大脑结构之间的机制联系.

主要方法:

使用英国生物银行血蛋白质组数据 (N=45,540) 的全蛋白质组关联研究 (PWAS).
针对AD的全基因组关联研究 (N=487,511).
对AD和轻度认知障碍 (MCD) 的纵向分析,横截面海马体积研究和蛋白质-蛋白质相互作用网络分析.

主要成果:

确定了30种与AD相关的血蛋白,其中包括13种新型候选蛋白 (例如FES,LRP11,HDGF).
在纵向研究中,PILRB和FES显示了与AD和/或MCD的关联.
LRP11水平与海马体体积增加和AD风险降低相关,而HDGF水平与海马体积减少和AD风险增加相关.

结论:

发现了13种与AD风险和海马体积相关的新型血蛋白候选物.
在已识别的蛋白质 (PILRA,PILRB,FES,LRP11) 和AD病理学之间建立了潜在的机制联系.
这些发现为AD病原和潜在的生物标志物提供了新的见解.

关键词:

阿尔茨海默氏症的疾病是阿尔茨海默氏症.遗传调节是一种基因调节.在海马体内,海马体的体积.血蛋白质组中的血蛋白质组整个蛋白质组的关联研究研究.

更多相关视频

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Published on: April 10, 2014

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...